Transmedics Group Inc
NASDAQ:TMDX

  • LAST PRICE
    94.1300
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    104.8900/ 1
  • Ask / Lots
    107.0000/ 1
  • Open / Previous Close
    96.0000 / 94.1300
  • Day Range
    93.0003
    97.8000
  • 52 Week Range
    36.4201
    99.6300
  • Volume
    1,241,503

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Yesterday

      Show headlines and story abstract

    • 6 hours ago by Dow Jones
      Companies Mentioned: TMDX

      By Stephen Nakrosis

      Shares of TransMedics were trading above record highs in Tuesday's after-hours session, following the release of first-quarter financial results that topped some analysts' expectations.

    • 9 hours ago by MT Newswires
      Companies Mentioned: TMDX
      04:27 PM EDT, 04/30/2024 (MT Newswires) -- ...

    • 9 hours ago by PR Newswire
      Companies Mentioned: TMDX

      TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter ended March 31, 2024.

    • 9 hours ago by Dow Jones
      Companies Mentioned: TMDX
      Total cost of revenue 36,888 12,788 ---------------------------- --------------------------- Gross profit 59,962 28,766 ---------------------------- --------------------------- Gross Margin 62 % 69 % Operating expenses: Research, development and clinical trials 11,380 5,871 Selling, general and administrative 36,161 24,984 Total operating expenses 47,541 30,855 ---------------------------- --------------------------- Income (loss) from operations 12,421 (2,089) ---------------------------- --------------------------- Other income (expense): Interest expense (3,598) (1,091) Interest income and other income (expense) 3,570 555 ---------------------------- --------------------------- Total other expense, net (28) (536) ---------------------------- --------------------------- Income (loss) before income taxes 12,393 (2,625) Provision for income taxes (196) (11) ---------------------------- --------------------------- Net income (loss) $ 12,197 $ (2,636) ============================ =========================== Net income (loss) per share: Basic $ 0.37 $ (0.08) Diluted $ 0.35 $ (0.08) Weighted average common shares outstanding: Basic 32,760,190 32,260,267 Diluted 34,678,895 32,260,267 TransMedics Group, Inc. CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands) (unaudited) March 31, 2024 December 31, 2023 --------------------------- ------------------------- Assets Current assets: Cash $ 350,217 $ 394,812 Accounts receivable 81,942 63,576 Inventory 48,541 44,235 Prepaid expenses and other current assets 7,606 8,031 --------------------------- ------------------------- Total current assets 488,306 510,654 Property, plant and equipment, net 214,421 173,941 Operating lease right-of-use assets 6,226 6,546 Restricted cash 500 500 Goodwill 11,990 11,990 Acquired intangible assets, net 2,303 2,354 Other non-current assets 85 62 Total assets $ 723,831 $ 706,047 =========================== ========================= Liabilities and Stockholders' Equity Current liabilities: Accounts payable $ 9,225 $ 12,717 Accrued expenses and other current liabilities 36,852 38,221 Deferred revenue 2,060 1,961 Operating lease liabilities 2,086 2,035 --------------------------- ------------------------- Total current liabilities 50,223 54,934 Convertible senior notes, net 447,835 447,140 Long-term debt, net of discount and current portion 59,141 59,064 Operating lease liabilities, net of current portion 7,161 7,707 --------------------------- ------------------------- Total liabilities 564,360 568,845 --------------------------- ------------------------- Total stockholders' equity 159,471 137,202 --------------------------- ------------------------- Total liabilities and stockholders' equity $ 723,831 $ 706,047

    • 9 hours ago by Dow Jones
      Companies Mentioned: TMDX

Peers Headlines